Idasanutlin
Cat.No:II0870 Solarbio
CAS:1229705-06-9
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Apoptosis >
IdasanutlinCAS:1229705-06-9
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 1229705-06-9 |
Name | Idasanutlin |
Molecular Formula | C31H29Cl2F2N3O4 |
Molecular Weight | 616.48 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD26142931 |
SMILES | O=C(O)C1=CC(OC)=C(NC([C@H]2[C@H](C3=C(F)C(Cl)=CC=C3)[C@](C4=CC=C(Cl)C=C4F)(C#N)[C@H](CC(C)(C)C)N2)=O)C=C1 |
Target Point | MDM-2 |
Passage | Apoptosis |
Background | Idasanutlin is a potent and selective MDM2 antagonist capable of inhibiting p53-MDM2 binding. |
Biological Activity | Idasanutlin 是一种有效,选择性的 MDM2 拮抗剂,能够抑制 p53-MDM2 的结合,IC50 值为 6 nM。[1-2] |
IC50 | 6nM(p53-MDM2)[1] |
In Vitro | Idasanutlin抑制细胞增殖,IC50为30 nM,诱导剂量依赖性p53稳定,细胞周期停滞,以及表达野生型p53的癌细胞中的细胞凋亡[1]。 Idasanutlin(300 nM或1.8μM)诱导SJSA骨肉瘤细胞凋亡[2]。 |
In Vivo | Idasanutlin(25 mg/kg po)在小鼠SJSA人骨肉瘤异种移植模型中导致肿瘤生长抑制和消退[1]。 Idasanutlin在SJSA异种移植模型中诱导细胞凋亡和抗增殖[2]。 |
Cell Experiment | 通过四唑染料测定评估细胞增殖。从浓度的对数与抑制百分比的图的线性回归确定细胞增殖的50%抑制(IC 50)或90%抑制(IC 90)的浓度。 |
Animal Experiment | 在10至12周龄时,给小鼠植入悬浮在无酚基质胶和PBS中的人SJSA骨肉瘤细胞(ATCC)的1:1混合物。将小鼠植入右侧,浓度为5×106个细胞,总体积为0.2mL。在大约第10天,根据肿瘤体积随机化动物,使得10只随机小鼠的所有组具有相似的起始平均肿瘤体积100至250mm 3。 Idasanutlin(RG7388)作为无定形固体分散体微量沉淀物粉末施用,其含有30%药物物质和70%乙酸琥珀酸羟丙基甲基纤维素聚合物,其在施用前立即重构为Klucel/Tween中的悬浮液,并且在给药后丢弃剩余的悬浮液。 |
Data Literature Source | [1]. Ding Q,et al. Discovery of RG7388,a potent and selective p53-MDM2 inhibitor in clinical development. J Med Chem. 2013 Jul 25;56(14):5979-83. [2]. Higgins B,et al. Preclinical optimization of MDM2 antagonist scheduling for cancer treatment by using a model-based approach. Clin Cancer Res. 2014,20(14),3742-3752 |
Unit | Bottle |
Specification | 2mg 5mg 10mg |
是一种有效,选择性的 MDM2 拮抗剂,能够抑制 p53-MDM2 的结合。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.